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88 The Journal of Thoracic and Cardiobjective: The number of surgical interventions for small-sized lung cancer has
ncreased with the development of computed tomography. We attempted to identify
linicopathologic characteristics of peripheral, small-sized, non–small cell lung
ancer to show the limitation of partial resection or segmentectomy.
ethods: A retrospective analysis of 143 patients who underwent a complete
esection for a peripheral non–small cell lung cancer of 2 cm or less in diameter was
erformed. The relationships between nodal involvement and other clinical factors
ere also assessed in patients who underwent a lobectomy plus node dissection.
esults: The overall 5-year survival rate was 88.1%. The 5-year survival rate was
00% for patients with a tumor of 1.5 cm or less. Survival for patients with
denocarcinoma histology was significantly better than for those with nonadeno-
arcinoma histology (P  .03). The 5-year survival rate for patients without lymph
ode metastases was 91.6%, whereas it was 62.5% for those with nodal involvement
P .01). Increase of prethoracotomy serum carcinoembryonic antigen level was an
ndependent predictor of a poor prognosis. Lymph node metastasis was significantly
ncreased in those with pleural invasion by the primary lesion and increased serum
arcinoembryonic antigen level. Fourteen (16.9%) of 83 patients with a tumor
iameter of larger than 1.5 cm had nodal metastasis.
onclusions: Nodal involvement should be considered in patients with non–small
ell lung cancer of 2 cm or less in diameter who show pleural invasion or an
ncreased carcinoembryonic antigen level. A lobectomy with node dissection is
ecommended for patients with a tumor larger than 1.5 cm, suspected pleural
nvasion, or prethoracotomy carcinoembryonic antigen level increase.
ith the development of high-resolution computed tomography (CT),
small-sized peripheral lung cancer has been more frequently encoun-
tered. At our institute, the ratio of resected cases with peripheral lung
ancer tumors sized 2 cm in diameter or less has increased from 17.1% of all lung
ancer cases in the period from 1992 through 1995 to more than 34.3% from 1996
hrough 1999 and 42.6% from 2000 through 2003. In addition, several reports have
uggested the feasibility of a limited operation for stage I early lung cancer.1,2
Recently, bronchioloalveolar carcinoma (BAC) showing ground-glass opacity
GGO) on chest CT images was identified as an independent entity among well-
ifferentiated adenocarcinomas.3 Patients with BAC with a GGO appearance, which
as been clarified to be less invasive, seldom have lymph node metastasis and
vascular Surgery ● May 2006
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G
TSsually have better outcomes compared with patients with
ypical adenocarcinoma.4-6 Thus patients with BAC de-
ected as a peripheral small-sized nodule could be good
andidates for a limited resection. Lymph node metastasis is
etected in a proportion of patients with small-sized periph-
ral lung cancer, even when the tumor size is smaller than
cm in diameter, and the risks of limited resection for these
atients have been documented.7,8 An inappropriate limited
esection can lead to an incomplete resection or misdiagno-
is of nodal staging, and such patients might miss a chance
o be cured or to receive adjuvant chemotherapy, which has
een shown to be effective for those with completely re-
ected non–small cell lung cancer (NSCLC).9 Thus it is
mportant to identify the characteristics of small-sized lung
ancer, including GGO lesions, to determine the appropriate
perative mode for each patient.
atients and Methods
atients
he records of 565 patients with NSCLC who underwent a thora-
otomy between 1992 and 2003 at Osaka University Hospital were
eviewed. Of those, we analyzed 143 patients with a small-sized
eripheral lesion of 2 cm or less in diameter who underwent a
omplete resection (Table 1). Patients treated with induction
herapy or those with multiple primary lesions were excluded.
ollow-up was completed in 133 of the patients, and the mean
ollow-up time for all was 52.1 months. We performed a lobec-
omy with systematic hilar and mediastinal lymph node dissection
n principle. A limited resection was indicated not only for high-
isk cases, including patients with low pulmonary function, car-
iovascular comorbidity, advanced age, and severe diabetes mel-
itus, but also for patients with GGO or a peripheral lesion smaller
han 1.5 cm in diameter. There were 15 compromised cases, and an
ntentional limited resection as a curative operation was performed
n 20 patients, including 12 lesions with a GGO appearance.
reoperative staging was done with chest and abdominal CT
canning, brain magnetic resonance imaging, and bone scintigra-
hy. Lymph nodes larger than 1 cm in the short axis on chest CT
mages were defined as clinical N factor positive. Transbronchial
ung biopsy or CT-guided needle biopsy was performed to obtain
histologic diagnosis. A proportion of patients with node swelling
ave been evaluated with fluorodeoxyglucose positron emission
omography since 1997. Postoperative staging was performed ac-
ording to the TNM classification.10 We defined a GGO lesion as
tumor occupied mainly by ground-glass shadows in at least two
hirds of the area on thin-section CT scans and noted as a GGO
esion by the attending radiologist. Otherwise, tumors with a
Abbreviations and Acronyms
BAC bronchioloalveolar carcinoma
CEA  carcinoembryonic antigen
CT  computed tomography
GGO ground-glass opacityartial ground-glass area were included in the solid tumor cate- c
The Journal of Thoracicory. Variables used for evaluation were age, sex, tumor size,
istology, tumor density, operation mode, lymph node metastases,
leural invasion, and prethoracotomy serum carcinoembryonic
ntigen (CEA) level.
tatistical Analyses
he probability of survival was calculated by using the Kaplan-
eier method.11 The prognostic influence of variables on survival
as analyzed with a Wilcoxon test and Cox regression.12 A 2 test
as used to compare the ratio between 2 groups.
esults
preoperative histologic diagnosis of lung cancer was
btained in 95 patients on the basis of results of CT-guided
eedle biopsy in 61 patients and transbronchial lung biopsy
n 34 patients. We performed fluorodeoxyglucose positron
mission tomography in 16 cases. Among those cases, 14
rimary tumors showed positive uptake, and 2 were nega-
ive. Positive uptake in lymph nodes was observed in 3
ABLE 1. Characteristics of 143 patients with resected
on–small cell lung cancer of 2 cm or less in diameter
Age, y 31-82 (average, 63)
Sex
Male 86
Female 57
Histology
Ad 127
Sq 14
Other 2
c-Stage
IA 131
IB 5
IIA 3
IIB 2
IIIA 2
c-N
c-N0 136
c-N1 5
c-N2 2
CT findings
Solid 102
GGO 41
Operative mode
Lobectomy 108
Partial resection 35
p-Stage
IA 123
IB 4
IIA 5
IIB 2
IIIA 9
d, Adenocarcinoma; Sq, squamous cell carcinoma; GGO, ground-glass
pacity; partial resection, including segmentectomy.ases (2 with node metastases, and 1 false-positive result),
and Cardiovascular Surgery ● Volume 131, Number 5 989
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G
TShereas negative results were shown in the remaining
3 patients (12 with no metastasis, and 1 false-negative
esult).
The overall 5-year survival rate for patients with periph-
ral NSCLC tumors of 2 cm or less in diameter was 88.1%,
hereas that for patients with tumors of 1.5 cm or less was
00% and that for patients with tumors of 1.6 to 2 cm was
4% (Figure 1). Patients with a tumor of 1.5 cm or less in
iameter survived longer than those with a tumor from 1.6
igure 2. Probability of survival for patients with peripheral,
mall-sized, non–small cell lung cancer who underwent a com-
lete resection according to histology of the primary lesion.
urvival for those with adenocarcinoma histology (Ad) was sig-
ificantly better than for those with nonadenocarcinoma histol-
gy (Non-Ad). Fourteen of the 16 nonadenocarcinoma cases
igure 1. Probability of survival for patients with peripheral non–
mall cell lung cancer who underwent a complete resection
ccording to tumor size. Survival for those with tumors of 1.5 cm
r less in diameter was better than for those with tumors of 1.6 to
.0 cm in diameter.6howed squamous cell carcinoma histology.
90 The Journal of Thoracic and Cardiovascular Surgery ● Mayo 2 cm in diameter. No patient with a tumor smaller than
cm showed recurrence over a mean follow-up period of
3.7 months.
According to histologic type, the 5-year survival rate for
atients with adenocarcinoma was 89.8%, which was sig-
ificantly better than that for patients with nonadenocarci-
oma histology (P  .03, Figure 2). Patients with nonade-
ocarcinoma histology consisted of 14 with squamous cell
arcinoma and 2 others. The 5-year survival rate for patients
ith a GGO lesion was 96.3%, whereas that for patients
ith a solid lesion was 85.1% (statistically not significant).
e did not observe recurrence in any of the patients with a
GO lesion, although 1 died of respiratory failure associ-
ted with chronic constructive pericarditis. When excluding
atients with GGO from the adenocarcinoma group, pa-
ients with an adenocarcinoma still showed a better survival
han those with nonadenocarcinoma histology (P  .05).
There was no significant difference in survival rates
etween the 108 patients treated with a lobectomy and the
5 patients treated with a segmentectomy or partial resec-
ion according to operation mode. Among the 35 patients,
ilar node sampling was preformed in 18 patients, and both
ilar and mediastinal node dissection or sampling was per-
ormed in 5 patients, whereas the remaining 12 patients
eceived no lymph node assessment. No metastasis was
ound in any of these resected nodes. The 5-year survival
ate was 88.0% for patients treated with a lobectomy and
7.0% for those treated with a limited resection.
The 5-year survival rate for patients without lymph node
etastasis was 91.6%, which was significantly better than
or those with nodal involvement, who had a survival rate of
igure 3. Probability of survival for patients with peripheral,
mall-sized, non–small cell lung cancer who underwent a com-
lete resection according to nodal involvement. Survival for those
ithout lymph node metastases was significantly better than for
hose with nodal involvement.2.5% (P  .01, Figure 3). Pleural invasion was patholog-
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G
TScally determined in 12 patients. The 5-year survival rate for
atients without pleural involvement was 89.6%, whereas it
as 75.8% for those with pleural invasion diagnosed patho-
ogically (statistically not significant).
Twenty-nine (21.8%) of 133 patients showed an increase
f preoperative serum CEA levels, and their 5-year survival
ate was 77.6%, which was significantly worse than the rate
igure 4. Probability of survival for patients with peripheral,
mall-sized, non–small cell lung cancer who underwent a com-
lete resection according to preoperative serum carcinoembry-
nic antigen (CEA) level. Survival for those with CEA level in-
rease (>5 ng/mL) was significantly worse than for those with a
ormal CEA level.
ABLE 2. Multivariate analyses of potential prognostic
actors in patients with resected non–small cell lung cancer
f 2 cm or less in diameter
ariables Hazard ratio 95% CL P value
umor size 1.136 0.900-1.433 .2835
istology
Ad 1.000
Non-Ad 3.514 0.793-15.561 .978
T finding
GGO 1.000
Solid 1.702 0.190-15.202 .6341
N metastasis
Negative 1.000
Positive 1.645 0.414-6.539 .4798
leural invasion
Negative 1.000
Positive 2.674 0.442-16.189 .2842
reoperative CEA level
WNL 1.000
5 ng/mL 4.666 1.161-18.751 .0299
L, Confidence limit; Ad, adenocarcinoma; CT, Computed tomographic;
GO, ground-glass opacity; LN, lymph node; CEA, carcinoembryonic anti-ten (cutoff value is 5 ng/mL); WNL, within normal limit.
The Journal of Thoracicf 92.1% for those with a normal CEA level (P  .01,
igure 4). Multivariate analyses using tumor size, histology,
T finding (solid or GGO), lymph node metastasis, pleural
nvasion, and prethoracotomy serum CEA level as variables
dentified only CEA level as an independent prognostic
actor (Table 2).
In addition, we analyzed the frequency of lymph node
etastasis by small-sized NSCLC in 108 patients treated
ith a lobectomy plus systematic hilar and mediastinal node
issection. Regarding the accuracy of preoperative nodal
valuation with CT scanning, sensitivity, specificity, accu-
acy, positive predictive value, and negative predictive
alue were 18.8%, 95.6%, 84.3%, 87.1%, and 42.9%, re-
pectively. The relationships between nodal metastasis and
linical factors are summarized in Table 3.
Lymph node metastasis was found in 1 (9.1%) of 11 and
(6.7%) of 15 patients with tumors sized less than 1 cm and
rom 1.1 to 1.5 cm in diameter, respectively, whereas 14
17%) of 82 patients with a tumor larger than 1.5 cm in
iameter had nodal involvement (statistically not signifi-
ant). Eight patients were associated with pathologic pleural
nvasion, of whom 4 (50%) had nodal metastases. The ratio
f metastasis-positive lymph nodes was significantly higher
n patients with pleural involvement (P  .05). In addition,
atients with an increased prethoracotomy serum CEA level
ad lymph node metastasis more frequently than those with
normal CEA level. Nodal involvement was found in 8
10.3%) of 78 patients with normal CEA levels, whereas 7
29.2%) of 24 with increased CEA levels had nodal metas-
ABLE 3. Relationship between clinical factors and lymph
ode metastasis in patients with small-sized non–small
ell lung cancer
actors Patient with LN metastases P value
umor size
0-1.5 cm 2/26 (7.7%)
1.6-2.0 cm 14/82 (17%) NS
leural factor
pP0 12/100 (12%)
pP1-2 4/8 (50%) .05
erum CEA
WNL 8/78 (10.3%)
5 ng/mL 7/24 (29.2%) .02
T finding
GGO 0/29 (0%)
Solid 17/79 (21.5%) NA
N, Lymph node; NS, statistically not significant; pP0, tumor without pleural
nvolvement beyond the elastic layer; pP1, tumor extending to elastic layer
ut not to the pleural surface; pP2, tumor extending to the pleural surface,
ccording to Japanese Lung Cancer Society criteria; CEA, carcinoembry-
nic antigen (cutoff value is 5 ng/mL); WNL, within normal limit; CT,
omputed tomography; GGO, ground-glass opacity; NA, not assessed.ases (P  .02). Notably, nodal involvement was observed
and Cardiovascular Surgery ● Volume 131, Number 5 991
i
2
t
D
I
r
o
a
a
b
m
a
f
p
d
i
a
a
o
t
p
i
s
5
r
t
f
t
o
p
w
w
o
o
w
s
b
r
s
t
i
f
T
p
C
t
r
s
c
l
d
l
a
p
d
w
s
c
h
s
r
n
s
p
t
d
b
I
p
c
h
p
c
s
h
g
t
i
f
h
i
i
l
a
l
s
n
a
m
s
I
s
T
p
b
t
m
General Thoracic Surgery Inoue et al
9
G
TSn 6 (60%) of 10 patients with a CEA level greater than the
-fold cutoff. We found no lymph node metastasis in pa-
ients with a GGO lesion.
iscussion
n the present study we focused on patients who underwent
esection of a peripheral, small-sized NSCLC tumor of 2 cm
r less in diameter and identified 3 prognostic factors,
denocarcinoma histology, pathologic nodal metastases,
nd preoperative serum CEA level, with the latter shown to
e the only independent prognostic predictor by means of
ultivariate analysis. We also identified pleural invasion
nd prethoracotomy serum CEA level increase as clinical
actors related to lymph node metastasis in an analysis of
atients treated with a lobectomy plus systematic node
issection. In addition, preoperative nodal staging with CT
maging for small-sized NSCLCs revealed a high specificity
nd positive predictive value, whereas sensitivity and neg-
tive predictive value were quite low.
Tumor size has been reported to be related to the survival
f patients with stage IA NSCLC and a nodule size of less
han 2 cm in diameter and has also been identified as a
rognostic factor.13 Survival analyses based on tumor size
n patients with stage I NSCLC have shown statistically
ignificant differences among those with tumors sized from
to 15 mm, 16 to 25 mm, and 26 to 36 mm.14 Another
eport showed that tumor size was an independent prognos-
ic factor in pN0 resected cases.15 In the present study we
ound node metastases in one sixth of our patients with a
umor larger than 1.5 cm in diameter compared with previ-
us studies that found lymph node metastasis in 28% of
atients with tumors smaller than 2 cm,7 15% of patients
ith subcentimeter-sized solid tumors,8 and 7% of patients
ith subcentimeter-sized tumors.16 Thus a limited resection
r omission of nodal clearance requires careful assessment
f node status. For tumors larger than 1.5 cm in diameter,
e recommend that a lobectomy with systematic node dis-
ection be chosen as a general practice. These results could
e part of the basic data to promote the prospective trial
egarding sublobar resection for small-sized lung cancer.
Nodal staging with CT imaging was reported to show a
ensitivity ranging from 50% to 81%, specificity from 56%
o 94%, and accuracy from 59% to 85% in studies published
n the last decade.17-21 However, the accuracy of nodal staging
ocused on small-sized lung cancer has not been clarified.
he present results revealed a high specificity and positive
redictive value for evaluation of metastatic nodes by using
T scanning for small-sized NSCLC tumors compared with
hose for all tumors because there were few false-positive
esults in preoperative nodal evaluations. Thus lymph node
welling associated with small-sized NSCLCs should be
onsidered as a sign of metastasis. w
92 The Journal of Thoracic and Cardiovascular Surgery ● MayHigh-resolution CT scanning can sometimes detect GGO
esions. The proportion of GGO area and tumor shadow
isappearance rate, calculated by using mediastinal and
ung windows in the CT images, have been shown to have
correlation with patient outcome.4,6 Another study re-
orted that most pure GGO tumors smaller than 1 cm in
iameter were BAC or atypical adenomatous hyperplasia,
hich are suitable candidates for thoracoscopic limited re-
ection.22 Furthermore, a recent prospective study con-
luded that limited resection procedures with intraoperative
istologic diagnosis for pulmonary nodules of 2 cm or
maller were satisfactory, showed accurate diagnoses cor-
esponding with those of frozen sections, and demonstrated
o recurrence.23 Because patients with GGO lesions did not
how nodal involvement or postoperative recurrence in the
resent study, we can propose a limited resection for pa-
ients with NSCLC with GGO lesions of 2 cm or less in
iameter.
Prethoracotomy serum CEA level has been reported to
e a good predictor of poor prognosis for patients with stage
NSCLC24-26 and was the only independent prognostic
redictor in the present study of small-sized NSCLC. It is
onsidered that a combination of CEA level and CT or
istologic findings might be more valuable to identify a
atient group with poor outcome.27,28 We also found a
orrelation between CEA level and nodal involvement in
mall-sized peripheral NSCLC. Interestingly, more than
alf of our patients with serum CEA levels that increased to
reater than the 2-fold cutoff had node metastasis. Because
he slight increase of CEA level could be caused by smok-
ng or other pulmonary disorders, we also analyzed the
requency of node metastases for patients with CEA levels
igher than 2-fold cutoff. These results indicate that a lim-
ted resection should be avoided in patients with CEA level
ncrease. Therefore we propose that measurement of CEA
evel is useful to select patients with advanced disease
mong those with peripheral, small-sized NSCLC.
Pleural invasion was frequently found in patients with
ymph node metastases, and several other studies have
hown pleural involvement to be a prognostic factor and
oted its clinical importance.29,30 However, a preoperative
ccurate evaluation of pleural factors is difficult to obtain by
eans of CT or magnetic resonance imaging, and macro-
copic findings during surgical intervention are unreliable.
t was recently reported that a unique CT finding, the
o-called pitfall sign, was able to predict pleural invasion.30
hus we consider that peripheral lung cancer with suspected
leural involvement on CT or intraoperative findings should
e treated with a lobectomy plus node dissection, even if the
umor is smaller than 2 cm in diameter.
We thank Professor Y. Ohno from the Department of Mathe-
atical Health Science, Osaka University Medical School, for help
ith statistical analyses.
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